LOC402377 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.238400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.808800E-01
Normal-vs-Stage2
1.079990E-01
Normal-vs-Stage3
1.699960E-01
Normal-vs-Stage4
8.252400E-01
Stage1-vs-Stage2
4.107600E-01
Stage1-vs-Stage3
4.326100E-02
Stage1-vs-Stage4
6.919800E-01
Stage2-vs-Stage3
2.325800E-01
Stage2-vs-Stage4
2.130200E-01
Stage3-vs-Stage4
1.997770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.731200E-01
Normal-vs-AfricanAmerican
7.408000E-01
Normal-vs-Asian
3.284800E-01
Caucasian-vs-AfricanAmerican
1.376990E-01
Caucasian-vs-Asian
9.614800E-01
AfricanAmerican-vs-Asian
3.746000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.536400E-01
Normal-vs-Female
2.139400E-01
Male-vs-Female
2.080800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.121600E-01
Normal-vs-Age(41-60Yrs)
2.485400E-01
Normal-vs-Age(61-80Yrs)
1.082960E-01
Normal-vs-Age(81-100Yrs)
3.865600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.096800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.346400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.329200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.406400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.422000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.458600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.229800E-01
Normal-vs-Daily Drinker
3.748800E-01
Normal-vs-Weekly Drinker
4.382800E-01
Normal-vs-Occasional Drinker
1.942230E-01
Normal-vs-Social Drinker
7.113400E-01
Non Drinker-vs-Daily Drinker
5.432200E-01
Non Drinker-vs-Weekly Drinker
8.947400E-01
Non Drinker-vs-Occasional Drinker
5.477800E-01
Non Drinker-vs-Social Drinker
2.944200E-02
Daily Drinker-vs-Weekly Drinker
4.813800E-01
Daily Drinker-vs-Occasional Drinker
2.550400E-01
Daily Drinker-vs-Social Drinker
2.609500E-02
Weekly Drinker-vs-Occasional Drinker
6.794200E-01
Weekly Drinker-vs-Social Drinker
8.476100E-02
Occasional Drinker-vs-Social Drinker
1.495050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.825420E-01
Normal-vs-Grade 2
1.321980E-01
Normal-vs-Grade 3
1.223770E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.662200E-01
Grade 1-vs-Grade 3
6.575600E-01
Grade 1-vs-Grade 4
1.825420E-01
Grade 2-vs-Grade 3
4.127800E-01
Grade 2-vs-Grade 4
1.321980E-01
Grade 3-vs-Grade 4
1.223770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.044400E-01
Normal-vs-NonDiabetic
1.125010E-01
Diabetic-vs-NonDiabetic
2.839800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.941600E-01
Normal-vs-NoPancreatitis
1.151370E-01
Pancreatitis-vs-NoPancreatitis
4.126000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.088800E-01
Normal-vs-N1
4.665000E-01
N0-vs-N1
3.253000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.856400E-01
Normal-vs-TP53-NonMutant
5.963800E-01
TP53-Mutant-vs-TP53-NonMutant
9.029600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
